QSI
Quantum-Si
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 2
Sell signal 2
consensus rating "Strong Buy"
Downward Gap
Revenue Beats Expectation
EPS Below Expectations
Key Stats
--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
About QSI
Quantum-Si Incorporated
A life sciences company that develops access to the proteome with single-molecule analysis and democratizing to researchers & clinicians
Biological Technology
06/24/2013
11/13/2020
NASDAQ Stock Exchange
149
12-31
Common stock
29 Business Park Drive , Branford, Connecticut 06405
--
Quantum-Si Incorporated was incorporated under the laws of the State of Delaware on June 24, 2013. Quantum-Si is an innovative life sciences company whose mission is to transform single-molecule analysis and popularize its use by providing researchers and clinicians with access to the proteome (a group of proteins expressed within cells). The company has developed a proprietary universal single-molecule detection platform that is applied to proteomics to enable next-generation protein sequencing and can be used for nucleic acid research.
Company Financials
EPS
QSI has released its 2024 Q4 earnings. EPS was reported at -0.23, versus the expected -0.19, missing expectations. The chart below visualizes how QSI has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
QSI has released its 2024 Q4 earnings report, with revenue of 1.19M, reflecting a YoY change of 198.00%, and net profit of -33.12M, showing a YoY change of -50.22%. The Sankey diagram below clearly presents QSI’s revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
